(EMAILWIRE.COM, April 16, 2019 ) According to the new market research report "Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) - Global Forecast to 2023", published by MarketsandMarkets™, The global apoptosis assays market is projected to reach USD 5.9 billion by 2023 from USD 3.6 billion in 2018, at a CAGR of 10.5%.

Don’t miss out on business opportunities in Apoptosis Assays Market. Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=9069428

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the apoptosis assays market. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Browse and in-depth TOC on " Apoptosis Assays Market "
125 - Tables
37 - Figures
205 - Pages
Request for Sample Report – https://www.marketsandmarkets.com/requestsampleNew.asp?id=9069428

Based on application, the apoptosis assays market is segmented into drug discovery & development, clinical & diagnostic applications, basic research, and stem cell research. In 2018, the drug discovery & development application segment is expected to account for the largest share of the global apoptosis assays market. The large share of this segment can be attributed to the rising incidence and prevalence of chronic and infectious diseases and increasing government support for developing new treatments for various human diseases.

On the basis of end user, the apoptosis assays market is segmented into pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and academic and research institutes. The pharmaceutical and biotechnology companies segment is expected to account for the largest share in 2018. The large share of this segment can be attributed to the increasing number of R&D activities undertaken by these companies for the development of biopharmaceutical products.

Download an Illustrative overview of the report – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9069428

Key Players:
Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US) are among a few major players in the industrial valve market.

Contact Information:
MarketsandMarkets™
Mr. Shelly Singh
Tel: 1-888-600-6441
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results